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ABSTRACT
FoxM1 is a member of the Forkhead family of tran-
scription factors and is implicated in inducing cell
proliferation and some forms of tumorigenesis. It
binds promoter regions with a preference for
tandem repeats of a consensus ‘TAAACA’ recogni-
tion sequence. The affinity of the isolated FoxM1
DNA-binding domain for this site is in the
micromolar range, lower than observed for other
Forkhead proteins. To explain these FoxM1
features, we determined the crystal structure of its
DNA-binding domain in complex with a tandem rec-
ognition sequence. FoxM1 adopts the winged-helix
fold, typical of the Forkhead family. Neither ‘wing’ of
the fold however, makes significant contacts with
the DNA, while the second, C-terminal, wing
adopts an unusual ordered conformation across
the back of the molecule. The lack of standard
DNA–‘wing’ interactions may be a reason for
FoxM1’s relatively low affinity. The role of the
‘wings’ is possibly undertaken by other FoxM1
regions outside the DBD, that could interact with
the target DNA directly or mediate interactions
with other binding partners. Finally, we were
unable to show a clear preference for tandem con-
sensus site recognition in DNA-binding, transcrip-
tion activation or bioinformatics analysis; FoxM1’s
moniker, ‘Trident’, is not supported by our data.
INTRODUCTION
In the ﬁeld of cancer biology, intense interest has recently
focused upon the Forkhead transcription factor FoxM1.
This is because its expression is tightly linked to a cell’s
proliferative potential (1). FoxM1 regulates the transcrip-
tion of a number of proteins required for cell-cycle pro-
gression (e.g. Cdc25C, Plk1, cyclin B2 and securin) (2) as
well as those that alleviate the oxidative burden incurred
by proliferating cells (3). As such, FoxM1 is expressed in
cycling cells, but becomes barely detectable when a cell is
quiescent or terminally diﬀerentiated. However, high
levels of FoxM1 may again be observed in states of un-
controlled cellular growth, as has been documented in a
number of cancerous cell-lineages (4–13). Moreover, some
tumors are known to become dependent upon FoxM1
over-expression for survival (3). This ‘addiction’ of
certain diseased states to overexpressed FoxM1 has led
to an eﬀort to characterize its potential as a therapeutic
chemotherapy target and several inhibitory compounds
are now being investigated (14–17).
FoxM1 is a member of the Forkhead Box (Fox) family
of transcription factors (18). Each Fox protein contains a
conserved stretch of 90 amino acids that comprise a
DNA-binding Forkhead box, a domain that serves to
target the proteins to genomic promoter regions.
Humans have over 40 Fox proteins, which are grouped
into subfamilies with consecutive alphabetic designations
(18). These Fox-subfamilies are varied and share little
sequence similarity or global domain-architecture, their
only unifying link being the conserved DNA-binding
domain. Across the super-family, the residues within this
domain have levels of sequence identity that approach
60%. Unsurprisingly, this results in the diﬀerent Fox
proteins having somewhat similar sequence-speciﬁcities.
Despite this overlap in speciﬁcity, each family member
regulates a distinct subset of genes during cell division
and development.
The transcriptional activity of FoxM1 is regulated in
part through dynamic interactions between its diﬀerent
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ponents: a central DNA-binding Forkhead box, an
N-terminal auto-inhibitory domain and a C-terminal tran-
scriptional transactivation domain. Cell-cycle dependence
of FoxM1’s transcriptional activity arises through control
mechanisms that inﬂuence inter-domain interactions by
controlling their phosphorylation status at deﬁned
cell-cycle stages. Expression of FoxM1 peaks in late G1
and early S-phase, but activity is only induced later in two
separate stages that initiate diﬀerent transcriptional
pathways, the ﬁrst in S/G2-phase and the second around
the G2/M transition. When ﬁrst expressed, the
transactivating domain of FoxM1 is kept inactive
through an ‘intra’-molecular auto-inhibitory interaction
with the N-terminal domain (19,20). From S-phase to
the G2/M transition the protein is then phosphorylated
at several sites by CyclinA/Cdk, disrupting the FoxM1
auto-inhibitory interaction and leading to the transcrip-
tion of the ﬁrst set of target genes (21,22). Full initiation
of FoxM1’s mitotic program requires a second round of
phosphorylation that further enhances transcriptional
activity. This occurs when the mitotic kinase Plk-1 recog-
nizes pre-primed FoxM1 as a substrate, resulting in
further phosphorylation of the C-terminal domain (23),
thus allowing the initiation of the FoxM1 transcriptional
pathways necessary for mitotic progression.
The conserved Forkhead box of FoxM1 adopts a
winged-helix-type fold commonly found in
DNA-binding proteins (24). The DNA speciﬁcity of this
domain has been previously characterized using coupled
pull-down and gel-shift assays (25,26). Such assays screen
a pool of random oligonucleotides identifying those that
bind to the FoxM1 DNA-binding domain (FoxM1-DBD,
residues 207–348) with high aﬃnity (1), and led to the
establishment of a core consensus site, TAAACA. This
site is similar to that known for other Forkhead
proteins: (G/A)(T/C)(A/C)AA(C/T)A. When the FoxM1
consensus sequence was ﬁrst identiﬁed in the gel-shift
assays it was also observed that the DBD preferentially
bound to tandem copies of the site (1). This was intriguing
as the Forkhead proteins are well conserved; if one
member of the family has a unique avidity for repeated
sequences this could represent a physiological diﬀerence
in the way it regulates transcription. We were thus
interested in the mechanism by which FoxM1 might
induce an allosteric increase in its aﬃnity for tandem con-
sensus sites. In this paper, we present the ﬁrst crystal struc-
ture of the human FoxM1 DBD, in complex with a
tandem promoter-like recognition sequence. We then
combine the structural information with DBD aﬃnity
measurements for FoxM1 recognition site variants, tran-
scription activation assays and bioinformatics searches,
in an eﬀort to understand the mechanism of action of
the protein.
METHODS
Protein production
The FoxM1C construct (residues 222–360) was cloned
into a pET-28-based vector with the N-terminal tag
MAHHHHHHSAALEVLFQGPG. This was trans-
formed into Escherichia coli BL21 (DE3) and grown at
37 C until reaching an Abs600nm of 0.8–1.0, protein was
induced at 15 C for 16h by adding 0.5mM IPTG.
Bacteria were harvested by centrifugation and resus-
pended in 100ml of buﬀer A (20mM Tris pH 8.0,
500mM NaCl, 2mM Imidazole, 0.5mM TCEP). After
which they were lysed and then cleared by high-speed cen-
trifugation before loading on a Ni–NTA metal aﬃnity
column (Qiagen Valencia, CA, USA). After washing the
protein was eluted in buﬀer A containing 400mM imid-
azole and the ﬁrst 17 tag residues removed by overnight
cleavage using human rhinovirus 3C protease. The
product was then loaded on a Superdex G75 16/60
HiLoad size exclusion column (GE Healhcare Life
Sciences) equilibrated in buﬀer A. FoxM1C.222.360
eluted as a monomer with the main peak pooled and
concentrated to 15–20mg/ml, ﬂash-frozen in liquid
nitrogen and stored at  80 C until required. Protein con-
centration was determined through 280nm absorbance
measurements in the presence of 6M guanidinium hydro-
chloride (Abs 1g/l=1.78).
Crystallization
The oligonucleotides aaattgtttataaacagcccg and
ttcgggctgtttataaacaat were dissolved in water and
heat-annealed. For crystallization protein, DNA
and buﬀer A were mixed to give a ﬁnal concentration
of 12mg/ml protein (0.72mM) and 0.5mM
Fm1-2x-19nt-aa/tt oligonucleotide. The mixture was
incubated for 30min on ice prior to being set in a
96-well sitting-drop format using 75ml reservoirs and
drops consisting of 400nl protein/DNA mixed with
400nl of reservoir. Crystal grew in 24% w/v PEG 3350
and 0.2M sodium malonate and was serially transferred
into the same solution with an additional 25% v/v
Ethylene Glycol for cryoprotectant. Diﬀraction data
were collected at 100K at the European Synchrotron
Radiation Facility on beamline ID23-1. The data thus
obtained were integrated and scaled at 2.2A ˚ using
Mosﬂm and Scala.
Phases were obtained by Molecular Replacement using
AMoRe (27) and a single protein monomer of FoxK1
[pdb: 2C6Y (28)]. Two molecules of FoxM1 and one
DNA duplex were present in the asymmetric unit. The
resulting electron density was clear allowing iterative
model building in Coot (29) and reﬁnement with
Refmac5 (27,30). The ﬁnal data reduction and reﬁnement
statistics are shown in Table 1.
Fluorescence anisotropy assay
The dissociation constants and IC50 values of the
FoxM1-DBD for diﬀerent consensus site DNA sequences
were measured by ﬂuorescence anisotropy (FP) assay.
Measurements were performed on a EnVision 2101
multilabel reader (Perkin Elmer) using 96-well optiplates
(Perkin Elmer). The excitation ﬁlter was a Perkin Elmer
X531 with a CWL of 531nm, while the P and S emission
ﬁlters were M579p with a CWL of 579nm, all measure-
ments were performed at 19 C. Each 50 TAMRA-labeled
4528 Nucleic Acids Research, 2010, Vol.38, No. 13oligonucleotide (Sigma Genosys) was dissolved in water
was heat annealed with its counterpart, the resulting
duplex was puriﬁed over a Superdex-75 10/300 Hi-Load
gel ﬁltration column (GE Healthcare). Dye concentration
was determined through UV–Vis measurements. Assays
were performed as either serial DBD-dilutions or in a
competition format to calculate EC50 values for the
longer oligonucleotides. The labeled DNA concentration
was 1nM, binding reactions were carried out in the buﬀer
20mM HEPES pH 7.5, 140mM NaCl, 1g/l chicken ov-
albumin, 0.05mM TCEP. Three measurements were col-
lected and averaged for each binding isotherm. The
competition oligonucleotides used were ERS6
(gggggaatCAAACAgaaag), ERS7 (aaagagagaCAAACA
gaga), ERS6/7 (ggaatCAAACAgaaagagagaCAAACA),
Ran20 (ccgatccgctcgcccgggcc), 2x-1 (ccgatGTTTTAAAC
Atgcc), 2x+1 (ccgaTGTTTAgTAAACAgcc), 2x (ggcTG
TTTATAAACAatcgg) and 1x (ccgatTGTTTAgcccgtgcc).
Luciferase reporter assays
A mammalian expression plasmid for the full-length
wild-type FoxM1c protein had been previously made
(21). The mutation L291Y within this plasmid was
generated by site-directed mutagenesis. Plasmids
encoding FoxM1 C (aa 1–600) and FoxM1 DNA
binding domain (DBD) (aa 210–378) were subcloned as
N-terminal ﬂag-tagged or myc-tagged versions in
pCDNA-3 (Invitrogen) by using standard techniques.
U2OS cells (osteosarcoma human cells) were maintained
in DMEM medium with 6% fetal calf serum and antibiot-
ics. Cells were transfected with plasmid DNA using the
standard calcium phosphate transfection protocol. After
transfection, cells were synchronized in G1/S with thymi-
dine (2.5mM, 24h) and in G2/M by releasing the
cells from the thymidine block in fresh medium for 14h.
For competition experiments, non-synchronized cells were
collected 48h after transfection. Luciferase activity was
determined using the dual luciferase kit (Promega) accord-
ing to the manufacturer’s instructions. Relative luciferase
was expressed as the ratio of ﬁreﬂy luciferase activity to
control Renilla luciferase activity. For western blot
analysis, protein concentration in the luciferase lysates
was determined by Bradford assay (Bio-Rad).
Equivalent amounts were subjected to SDS-PAGE and
western blotting was carried out with the indicated
antibodies. FoxM1 (C-20) and Actin (I-19) were from
Santa Cruz. Anti-ﬂag (M2) and anti-myc (9E10) were
from Sigma and Covance, respectively.
Bioinformatics
The 3000bp upstream of transcripts from human or mam-
malian promoter sequences (Ensembl version 51) were
searched for: the Forkhead consensus motif TAACA or
ATTTGT; the palindrome TGTTTA.{0,5}TAAACA; and
the palindrome TAAACA.{0,5}TGTTTA. Motif conser-
vation is computed as the fraction of promoters of verte-
brate orthologs that contain a hit to this motif in a similar
position to that of the human motif hit, applying a 1%
window to allow for small shifts.
RESULTS
The FoxM1-DBD recognizes its consensus and natural
promoter sequences with micromolar aﬃnity
To characterize the DNA-binding behavior of FoxM1, we
used ﬂuorescence polarization anisotropy experiments to
measure the aﬃnity of the DBD for its consensus
sequence. The FoxM1-DBD (residues 222–360) was ex-
pressed in bacteria and puriﬁed to homogeneity. Aﬃnity
measurements were performed using a TAMRA-labeled
11bp DNA containing a consensus ccaTAAACAac
sequence. In the conditions used, wild-type
FoxM1-DBD binds to this sequence with an apparent dis-
sociation constant (KD) of 7000±300nM (Figure 1A).
The FoxM1-DBD thus has a micromolar aﬃnity for the
classical Forkhead consensus site. This is at least an order
of magnitude lower than the aﬃnity reported for the
FoxO3a-DBD [KD of 300nM for a 26bp oligonucleotide
(31)] and four orders of magnitude lower than that
reported for the FoxD3-DBD [KD of 0.3nM for a 25bp
oligonucleotide (32)].
The previously described consensus sequences are
merely the best derived from past in vitro experiments.
The physiological promoters recognized by FoxM1 will
be related, but not necessarily identical. To examine if
natural promoter sequences transactivated by FoxM1
have diﬀerent properties, we used 11bp and 19bp
sections of the S6 and S7 response elements of the
estrogen receptor (ERa) promoter(6), as well as a 21bp
sequence containing the combined S6/S7 element. For this
experiment, we had to use competition ﬂuorescence an-
isotropy assays to compensate for the reduced tumbling
times of the longer DNA. The competition assay was
set up containing 20mM of the FoxM1-DBD, 1nM of
labeled 11bp DNA and a dilution series of diﬀerent
Table 1. Data collection and reﬁnement statistics
pH 7.5
Data collection statistics
Number of crystals 1
Space group C2221
Unit cell: a, b, c (A ˚ ) 63.1, 119.8, 153.0
Resolution Limits (High) (A ˚ ) 38.1–2.2 (2.3–2.2)
Completeness (%) 91.9 (61.3)
Number of reﬂections 25545
Multiplicity 5.0 (4.4)
Rpim 0.030 (0.213)
<I/s(I)> 17.2 (3.2)
Wilson’s B-factor (A ˚ 2) 48.1
Model reﬁnement statistics
Rfactor
a 0.203
Rfree
a 0.234
Number of protein atoms 1644
Number of DNA atoms 945
Number of waters (ions) 163 (2)
Ramachandran plot
b
– favored (%) 96.1
– outliers (%) 0.0
RMS bond, Z-score (A ˚ )
a 0.009, 0.370
RMS angle, Z-score ( )
a 1.45, 0.538
aCalculated within Refmac 5(30).
bCalculated with Moprobity (46).
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ﬁnd that the EC50 values between the control 11bp con-
sensus site (61000nM), the 11bp S6 element (80000nM),
and the 11bp S7 element (71000nM) to be the same
within their 99% conﬁdence level. The EC50 values for
the longer, 19bp sequences of the S6 element
(29000nM), the S7 element (12200nM) as well as the
S6/S7 element (16800nM) are signiﬁcantly lower than
these for their 11bp counterparts, taking into account
the 99% conﬁdence levels. From these experiments, we
conclude that FoxM1-DBD has similar aﬃnity to the
core recognitions sites of the natural promoters and the
consensus site. The aﬃnity for longer promoter sequences,
appears tighter, but at most by a factor of two, which
would be still much less than what has been reported for
other Fox family members for similar size recognition
sequences.
Structure determination of the FoxM1-DBD in complex
with its consensus sequence
To understand why the FoxM1-DBD has a lower aﬃnity
for its consensus sequence compared to other Forkhead
proteins we sought further details about the mechanism
through which it recognizes DNA. We were able to
obtain a 2.2A ˚ X-ray crystal structure of the DBD
(residues 222–360) in complex with a DNA duplex con-
taining two consensus sites (see Table 1 for data collection
and reﬁnement statistics). This 19-bp duplex contained
two FoxM1 recognition sites in a palindromic orientation
(atTGTTTA-TAAACAgcccg) and cohesive ends to aid
self-association during crystallization. Phases were
obtained by molecular replacement of FoxK1 [pdb code
2C6Y (28)] yielding electron density that allowed a model
to be built and reﬁned (Figure 2A and B). Due to the
palindromic sites two FoxM1 protein molecules are
bound per DNA duplex, with the asymmetric unit con-
taining one of these protein:DNA complexes. Our model
consists of: the entire double-stranded DNA molecule;
2 magnesium ions; 163 water molecules; FoxM1 residues
232–321 in the A molecule and residues 235–327 in the B
molecule (Figure 2A and B). The two protein molecules
are nearly identical in structure [RMSD of 0.73A ˚ over
88Ca atoms as calculated by RAPIDO (33)]. Neither
molecule displays electron density for the ﬁrst
10N-terminal residues or the 25–30C-terminal ones,
indicating a degree of disorder in these regions.
The winged-helix fold
The FoxM1 DBD adopts a Forkhead winged-helix fold.
This is constructed from three a-helices and three
b-strands with the topology abaabb (Figure 2B). The
Figure 1. DNA-binding properties of FoxM1-DBD as measured by
ﬂuorescence anisotropy. (A) Anisotropy measurements of 1 nM of
TAMRA-labeled consensus sequence binding to diﬀerent concentra-
tions of FoxM1-DBD (residues 222–360). Error bars represent
standard deviations of three diﬀerent experimental measurements. (B)
Competition assays in which increasing concentrations of non-labeled
oligonucleotides derived from estrogen receptor alpha promoter
elements are added allowing the determination of relative aﬃnities ex-
pressed as EC50 values. (C) Anisotropy measurements using the
TAMRA labeled consensus sequence as in (A), a sequence without
the A(i+4) consensus base and a non-consensus (random) sequence.
(D) Competition assays in which increasing concentrations of various
non-labeled palindromic oligonucleotides are added allowing the deter-
mination of relative aﬃnities expressed as EC50 values.
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into a squat-cylindrical volume that sits perpendicularly
alongside the DNA; an arrangement that allows helix h3
to insert into the major groove where it can make
sequence-speciﬁc DNA contacts. The mixed three-
stranded b-sheet lies at one end of this helical bundle
with strands s2 and s3 running parallel to the
DNA-helix, contacting the phosphate-backbone at
several points. The ﬁrst ‘wing’ of a winged-helix-fold de-
scribes the loop between these s2 and s3 strands while the
second ‘wing’ refers to the residues immediately
C-terminal to s3. An additional small 310-helix lies
within the loop connecting h2 to h3, a structure also
present in FoxD3 (34), FoxC2 (35), FoxO4 (36) and
FoxQ1 (37).
Protein–DNA recognition
FoxM1 makes both sequence-speciﬁc and sequence-
independent protein–DNA contacts. Sequence-
independent contacts are in the majority and are primarily
made between the DNA backbone (Figure 3A) and three
regions of the protein: the N-terminus of h1; residues
within strands s2 and s3; and the N-terminus of h3. This
last set of interactions is mediated through the hydration
sphere of a coordinated magnesium ion also present in
some other Fox-DBD structures (28,38). To describe the
sequence-speciﬁc FoxM1 interactions we label the consen-
sus site as
iTAAACA
i+5 where i is the ﬁrst base of the two
palindromic sites (base 11 in chain C and base 14 in chain
D of the DNA, Figures 2C and 3).
Direct contact with the DNA bases is mainly made
through protein residues from within h3 (Figures 2C and
3). As in other Fox proteins, the major contributors to
speciﬁcity are three invariantly conserved residues:
Asn-283, Arg-286 and His-287. Speciﬁcity for the
A(i+2) base derives from two hydrogen bonds with the
side chain of Asn-283 (Figure 3), while the A(i+1) speci-
ﬁcity arises from a hydrogen bond between its comple-
mentary base and His-287 (Figure 2). The reported
speciﬁcity for the other bases in the FoxM1 consensus
sequence are harder to determine from the crystal struc-
ture alone; indirect water mediated interactions with the
complimentary bases possibly yield a preference for the
A(i+3) position (via Asn-286) and the C(i+4) position
(via Arg-286). Additionally a van der Waals contact
between Ser-290 and the T(i) base could promote selectiv-
ity at this position. We observe no contact between the
A(i+5) base and the protein.
Consensus sequence speciﬁcity
In light of our ﬁndings, we proceeded to examine the
aﬃnity of the FoxM-DBD for its consensus site as well
as its ability to discriminate against other DNA sequences.
Figure 2. Crystal structure of the FoxM1 DNA binding domain. (A)
cartoon representation of the macromolecules present in the asymmet-
ric unit. The FoxM1 A molecule is shown with helices in red and
b-strands in yellow and loop regions in green. The B molecule has
the same coloring but with helices in purple. (B) A magniﬁed represen-
tation of the FoxM1 A subunit bound to the major groove of the
DNA. Secondary structural elements and the Nand C-termini are
labeled. (C) The residues and bases involved in sequence-speciﬁc
DNA-protein interactions are shown in stick-representation. Each
residue and base is labeled, the chain identiﬁers of the DNA bases
are also shown. (D) Close-up view of the protein-protein interface at
the site of the palindromic psuedo 2-fold axis. Water molecules are
shown in pink and magnesium ions in green.
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above, with diﬀerent oligonucleotides. The experiment
shown in Figure 1C gave KD values for the
FoxM1-DBD of: 7500±800nM for the standard consen-
sus sequence ccaTAAACAac similar to previous measure-
ments (Figure 1A); 20500 ± 1500nM when the
speciﬁcally recognized A(i+2) base is mutated to a G
(ccaTAgACAac); and 26000±1700nM for the random
non-consensus sequence gcaggtcgacg. Thus, the
FoxM1-DBD has only a 3–4-fold higher aﬃnity for its
consensus site over random DNA. Moreover, altering
the A(i+2) base, which based on the structure is the
major sequence-speciﬁc readout within the consensus
site, is suﬃcient to considerably abrogate this weak dis-
crimination. One reason the FoxM1-DBD may bind so
weakly is its lack of ‘wing’-interactions. It is noteworthy
that truncation of the wing-2 residues 240–253 in FoxO3a
resulted in a 5-fold drop in aﬃnity [Kd of 1500nM (27)],
yielding binding with a similar order of magnitude to what
we observe for FoxM1.
FoxM1 had previously been shown to have an increased
aﬃnity for tandem consensus recognition sites, even being
named Trident to showcase an observed preferential
binding of triple-consensus sequences (1). Given that in
our structure the two molecules binding the tandem con-
sensus sites are in close proximity, we wished to examine if
there was an obvious means by which the FoxM1-DBD
could preferentially bind such tandem sequences in
solution.
Tandem sequence aﬃnity
To determine whether tandem sites could enhance the
aﬃnity of the FoxM1-DBD for its consensus sequence,
we measured the aﬃnities of longer DNA sequences,
using the competition ﬂuorescence anisotropy described
above. We have used oligonucleotides containing one con-
sensus site (x); two consensus sites (2x); two consensus
sites separated by 1 base (2x+1); two consensus sites
one base closer (2x-1) or non-consensus DNA (Ran). As
shown in Figure 1D, the competition curves for each of
these experiments show that they bind with similar
aﬃnities. The respective EC50 values are 7000nM,
9000nM, 6000nM, 9000nM for the tandem variants,
and ﬁnally 18000nM for the non-consensus site. From
these data, we can conclude that the FoxM1-DBD does
not display a noticeably higher aﬃnity for DNA with
two-tandem Forkhead consensus binding sites.
Next, we wished to examine if the contacts between the
two protein molecules bound to the palindromic DNA in
our structure are likely to represent a true interaction
interface that could facilitate increased aﬃnity for
tandem recognition sites.
Protein ‘dimerization’ interface analysis
We looked for evidence of interaction between the FoxM1
A and B molecules that were bound to the tandem palin-
dromic repeats of the DNA in our structure. The palin-
dromic inter-molecule interface shows minimal contacts,
the only instance of a direct interaction being between the
two Leu-291 side chains. Notably, this residue is
conserved in almost all Fox-DBDs. A network of
ordered water molecules also bridges the two His-287
side chains (Figure 2D). PISA (39) assigns this interface
a buried surface area of 41.2A ˚ 2 and a relatively minor
solvation free energy gain upon formation ( 0.9kcal/
mol). In addition, there is no obvious protein–protein
interface between symmetry-related subunits, consistent
with the model of the isolated DBD being monomeric as
reported (40).
We established no obvious mechanism from our struc-
ture that would favor tandem repeat recognition in the
FoxM1-DBD, but such an arrangement could still be
physiologically relevant. Thus, we next wished to deter-
mine if the full-length protein could still utilize such an
oligomerization mechanism like that seen in the arrange-
ment of molecules in the crystal structure as mediated
through a Leu-291 interaction.
Mutation of the ‘dimerization’ interface does not aﬀect
transcription assays for the full-length FoxM1 protein
To determine if a change in transcriptional activity is
observed when the DNA-induced FoxM1 dimer is pre-
vented from forming, we expressed the full-length
FoxM1c protein and an L291Y mutant. To prevent
tandem repeat recognition we used this mutation as
our structure suggests a large residue at that position
would result in steric hindrances that inhibit dimer
formation (Figure 2D). A luciferase reporter assay was
used to monitor the transcriptional activity of the
Figure 3. Interactions made between FoxM1 and its cognate DNA. A
two-dimensional representation is shown that highlights the interactions
made between FoxM1 and the DNA. The phosphate-sugar backbone
for the oligonucleotide C-chain is on the left and Dchain on the right.
Next to each backbone sugar is the single letter code of the respective
base. Chemical moieties that are seen to be the correct distance in the
crystal structure to form hydrogen bonds (solid line) or van-der-Waals
interactions (brackets) with residues in the A protein subunit are
indicated. Similar interactions are observed for the
palandromicly-equivalent residues of the DNA and the B protein
subunit.
4532 Nucleic Acids Research, 2010, Vol.38, No. 13wild-type protein and the L291Y mutant in U2OS cells
(Figure 5A). Protein was expressed in transfected cells
synchronized in either G1/S-phase or G2/M-phase, and
transcriptional activity was then measured from a respon-
sive reporter bearing six tandem canonical
Forkhead-binding elements [6xDBE (41)]. As expected,
cells transfected with wild-type FoxM1c showed increased
transcription of the luciferase gene compared to controls.
Moreover, transcriptional activity increased when cells
entered mitosis, which is when further FoxM1 activation
is expected following its phosphorylation by upstream
kinases. The FoxM1c L291Y mutant also expressed abun-
dantly and resulted in considerable luciferase activity.
When transcriptional activity was normalized by protein
expression level, the L291Y mutant and wild-type
FoxM1c are seen to be equally able to promote transcrip-
tion from tandem Forkhead consensus sites.
Tandem Forkhead consensus sequences are rare and
poorly conserved in the genome
Although we were unable to detect an obvious preference
of FoxM1 for tandem consensus sites, our inability to
detect enhanced aﬃnity may be due to missing experimen-
tal factors that are present in vivo and promote enhanced
recognition in the full-length protein. Therefore, we
wished to examine whether tandem Forkhead consensus
sequences were conserved in the promoter regions of ver-
tebrate genomes. To ascertain whether this was the case
we performed a computational search of the 3000bp
upstream of each transcript in the human genome to de-
termine whether such sites exist and whether they are
conserved. We ﬁrst searched for the single-site minimal
consensus sequence TAAACA or its complement within
promoter regions (Figure 5B). As multiple Forkhead
proteins are expected to bind to this or similar sites, it is
not surprising that in many genes one or more conserved
copies of the sequence can be found. In contrast, if the
palindromic sequence TGTTTA. TAAACA (Figure 5B)
or the same sequence with up to 5bp of separation
between the repeats (TGTTTA.{0,5}.TAAACA) are
searched for, a statistically insigniﬁcant number of hits
are observed (only four promoters have a palindromic
sequence with a conservation cutoﬀ of 0.1). Thus,
tandem arrays of Forkhead consensus sequences do not
appear to be highly conserved within vertebrate genomes.
It must be noted that such a search is complicated by both
the small size of the consensus site and the apparent prom-
iscuity of some isolated Forkhead domains as evidenced
by the relatively low discrimination of FoxM1.
The FoxM1 ‘wing’ regions adopt unique conformations
that are not involved in DNA binding
The FoxM1 DBD has fewer features deﬁning speciﬁcity
than other Forkhead proteins, and the two ‘wings’ of the
winged-helix fold make minimal contacts with the DNA.
The ﬁrst wing of the fold, consisting of the loop between
s2 and s3, is one of the less-conserved regions of the DBD
and varies in both length and sequence in diﬀerent Fox
proteins. In FoxD3 wing1 is 11-residue long (Figure 4)
and NMR-measurements (42) showed that it associates
dynamically with the minor groove of the DNA
inﬂuencing binding. Moreover, in the crystal structure of
the DNA-bound complex between FoxP2 and NFAT (43)
(Figure 4) wing1 is seen to be a primary site of interaction
between the two transcription factors. These facets of this
loop imply it may be an important region within
Forkhead proteins that acts as a transcriptional cofactor
recognition site and due to its variability may lend a
degree of ‘speciﬁcity’ to the Forkhead regulatory
networks by coupling the relatively conserved Forkhead
consensus site with those from diﬀerent transcription
factors.
The ﬁrst wing of FoxM1, which is only 6-residue long, is
short and reminiscent of the FoxP2 structure in which the
loop is so abridged it consists of only a tight b-turn (38)
(Figure 4). In the asymmetric unit, the two FoxM1 mol-
ecules have their wing1 loops in slightly diﬀerent conform-
ations; the A-molecule wing1 crosses the unligated
phosphatebackbone oftheDNAcohesiveend andisthere-
fore less likely to represent a physiologically relevant state.
However,inbothsubunits,theloopdivergesawayfromthe
DNA and does not contact the minor groove, as for
example in FoxD3 (44) or FoxK1a (28). Consequently,
like in the FoxP2 structure, this ‘wing’ in FoxM1 is
unable to directly aﬀect protein–DNA interactions.
The second wing of the winged-helix fold describes a
loosely structured loop at the extreme C-terminus of the
DBD (Figure 3B). In other Fox proteins, 10–20 amino
acids after s3 are stretches of charged positive rich
sequences that can interact with the DNA. These
positive residues follow a solvent exposed 4th helix
within the wing, a helix that may dynamically form
upon DNA binding. The charged wing2 residues may
interact with the DNA through diverse means, contacting
the phosphate backbone in FoxO1 (45) and FoxO4, con-
tacting bases via the minor groove of the DNA in FoxK1
(28) and FoxD3 (42); or reconnecting with the major
groove in the case of FoxO3a (31). The C-terminus of
our FoxM1 structure diﬀers signiﬁcantly from these
DNA-bound Forkhead structures. We see no 4th helix
C-terminal to s3, although a helical turn does encompass
residues 311–314 (see C-terminus in Figures 2B and 4).
The residues C-terminal to the FoxM1-DBD instead
adopt a unique structure that consists of a sharp turn
leading into an extended loop packed perpendicularly
across h1. This loop diverges away from the DNA so is
not merely a diﬀerent conformation of the second wing
loop.
We next wanted to examine whether the lack of wing
regions in the FoxM1-DBD is a reason for the low
DNA-binding aﬃnity compared to other Forkhead
family members.
Low DNA biding aﬃnity is likely due to the lack of
‘wing’ regions in FoxM1-DBD
To test this, we performed further transcriptional assays.
Here, we out-compete the full-length protein’s ability to
transactivate its consensus promoter, by increasing con-
centrations of various other protein constructs which lack
transactivation domains. We expect that the construct
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out-compete the wild-type protein more eﬀectively from
these sites, and will result in lower transcriptional activity,
as measured by the luciferase reporter.
For this experiment we used our FoxM1-DBD and the
FoxO3-DBD, which has typical wings (Figure 3B) and 10
times higher DNA-binding aﬃnity in vitro. Under identi-
cal plasmid concentrations, the expressed FoxO3-DBD
out-competed full-length FoxM1 for promoter binding
at a level approximately equal to that of FoxM1-DBD
(Figure 5D, blue bars). However, FoxM1-DBD is much
higher expressed than FoxO3-DBD (see lower panel in
Figure 5D), indicating that, in fact, FoxO3-DBD
inhibits FoxM1 transactivation more eﬃciently than
FoxM1-DBD, as expected from its binding aﬃnity
in vitro. To emphasize this eﬀect, we normalized the tran-
scriptional activity to protein expression levels (Figure 5D,
light blue bars). This result indicates that the ‘winged’
FoxO3-DBD has greater ability to act as a dominant
negative, when compared to the ‘wingless’ FoxM1-DBD.
This is consistent with the hypothesis that the wing regions
missing in FoxM1-DBD result in the lower consensus site
aﬃnity.
Next, we wanted to examine if the missing wings of
FoxM1-DBD are likely ‘substituted’ by other regions in
the FoxM1 full-length protein, that display additional
interactions contributing to binding speciﬁcity.
Regions outside the FoxM1-DBD are likely involved in
target DNA interaction
To examine this hypothesis, we wanted to see if a FoxM1
construct with additional elements, but still lacking the
C-terminal transactivation domain, would be a better
competitor of full-length FoxM1, compared to
FoxM1-DBD alone. We used the competition transcrip-
tional assay described above, with FoxM1-DBD and a
construct lacking only the C-terminal transactivating
domain, C(1–600), extending both upstream and down-
stream of the FoxM1-DBD. The C(1–600) construct was
able to reduce luciferase production much more eﬀectively
than FoxM1-DBD (Figure 5C). This suggests that C(1–
600) binds promoter sites with higher aﬃnity than
FoxM1-DBD, and supports the concept that elements
additional to the FoxM1-DBD, either upstream or down-
stream of it, are important for DNA recognition, taking
the role of the ‘wing’ regions present in other Forkhead
family members.
DISCUSSION
We found that the FoxM1-DBD has an unusually low
aﬃnity for single copies of its Forkhead consensus
sequence. The low aﬃnities observed for the isolated
domain are anomalous and it seems highly unlikely that
the full-length FoxM1 transcription factor would be able
Figure 4. DNA bound Forkhead domains. Cartoon representation of the Fox proteins for which structures in complex with DNA are known. The
ﬁrst wing loop is highlighted in pink and the second in black. In Fox K2 and FoxP2 the fourth helix preceding wing2 is also highlighted. In the lower
right a superposition between FoxM1 (coloured as in Figure 2) and FoxO3 is shown detailing the diﬀerent conformations of the proteins Ctermini.
The FoxM1 C-terminus is colored teal.
4534 Nucleic Acids Research, 2010, Vol.38, No. 13to exert any coordinated response with such poor
discrimination.
To facilitate our understanding of FoxM1 promoter re-
cruitment we determined the structure of the
FoxM1-DBD in complex with DNA. This new structure
was both informative and puzzling. Surprisingly we
observed that the FoxM1-DBD lacks contacts between
the DNA and the loop regions described as the ‘wings’
of the winged-helix fold. Moreover, while the ﬁrst wing
loop does not contact the DNA the second wing loop is
entirely absent. The C-terminal residues of the DBD
instead form an extended structure distal from the DNA
unique to FoxM1. The loss of wing–DNA contacts pre-
sumably in part explains the low aﬃnity of FoxM1 for
single copies of its consensus sequence. Comparing the
ability of the (‘wingless’) FoxM1-DBD to the ‘winged’
FoxO3-DBDs to limit transcription in a reporter assay
supports this hypothesis. Moreover, we show indirectly
that a FoxM1 construct containing elements both
upstream and downstream of the FoxM1-DBD, has a
higher apparent aﬃnity for consensus sites in our tran-
scription reporter assay.
These observations argue that additional regions in
FoxM1, outside the DBD, increase the avidity of the
protein for its promoter regions. These sequences are
likely to directly interact with DNA promoter sequences,
increasing the aﬃnity and target site recognition speciﬁcity
of the full-length FoxM1 protein. Alternatively, these add-
itional regions maybe required to mediate post-
translational modiﬁcations or other interactions of the
FoxM1 protein that result in higher apparent DNA
binding aﬃnity. Further analysis will become possible
when structural information about the full-length
protein is available.
Despite crystallizing a construct that extended to
residue 360, any additional C–terminal residues that
could make up a DNA-interacting wing appear to
remain distant from the DNA and disordered. This
could imply two possibilities: that FoxM1 does not have
a 2nd wing-like loop, perhaps transferring this function to
another part of the full-length protein; or that this wing
does not bind to the minor groove but instead the major
groove of the DNA as in FoxO3a (31), in which case our
palindromic sequence may perturb its binding.
A major motivation to study the FoxM1 transcription
factor, apart from its biological interest and its profound
implication in cell proliferation and cancer, was its
reported preference for multiple Forkhead binding sites
occurring in tandem in either a back-to-forward (e.g. T
GTTTA-TAAACA) or forward-to-back (TAAACA-TG
TTTA) orientation (1). We wished to examine the struc-
tural means by which a preference for tandem sequences
could uniquely arise within the FoxM1 family member.
This question is especially intriguing as the Forkhead
DBDs are well conserved and any behavior distinguishing
FoxM1 from the other Forkhead transcription factors
may be related to its role in regulating cellular
proliferation.
To that end we used a forward-to-back tandem repeat
DNA for crystallization. This resulted in an arrangement
of DBDs with few inter-protein contacts and none that
could be described as being speciﬁc to FoxM1. Indeed,
we note that the FoxP2 structure of Stroud et al. (38)
displays an arrangement of DBDs similar to FoxM1 in
its asymmetric unit’s F- and J-molecules; This is despite
the fact that the oligonucleotide within this structure lacks
a palindrome-like sequence (i.e. the F-molecule is not
bound to a Forkhead consensus site) as well as the fact
that one of the molecules exists in a domain-swapped
form. That both FoxP2 and FoxM1 can form these
weakly interacting dimers when bound to DNA is
intriguing, and due to the conserved nature of the
residues involved could reﬂect a means of interaction by
which multiple Forkhead DBDs could associate.
However, two points should be held in mind: the ﬁrst is
that such an arrangement may also be promoted artiﬁcial-
ly through the requirements of crystallization; the second
is that all current Fox DBD structures are of truncated
constructs and not full-length proteins. DNA-induced
dimers could be either enhanced or entirely prevented by
the missing parts of the molecule. For FoxM1c this pos-
sibility was tested indirectly by comparing the transcrip-
tion rate of a reporter gene in cells expressing wild-type
protein or a mutant unable to form the arrangement of
molecules seen in our crystal structure. No fundamental
changes in transcriptional activity were observed, thus
indicating that this dimerization mechanism is either not
a part of all FoxM1-promoter recognition events, or plays
a relatively minor role in regulating transcription. We can
draw one ﬁrm conclusion from the structural data, which
is that we do not detail any means by which the isolated
FoxM1-DBD could have a unique aﬃnity for tandem
consensus sequences.
In the absence of further experiments, we conclude it is
unlikely that FoxM1 mediated transcription relies on
the direct recognition of tandem consensus sites. This con-
clusion is strengthened since we were unable to observe
conserved tandem Forkhead sequences in genomic
promoter regions. The initial gel-shift assays that
established the preference for tandem sequence recogni-
tion were possibly misled by the low aﬃnity of the
isolated FoxM1-DBD for its consensus sequence thus
leading to preferential identiﬁcation of multi-site
oligonucleotides. This scenario raises doubt about the
physiological signiﬁcance of such poorly conserved
multi-site sequences.
FoxM1 contains a central domain located C-terminal to
its DBD that plays a contextual role, inhibiting FoxM1c
mediated transcription from consensus Forkhead pro-
moters and activating promoters with c-myc like TATA
boxes (2). It could be hypothesized that this central
domain inﬂuences recognition of tandem consensus se-
quences by providing additional interactions to those
observed across the palindromic interface in the crystal
structure. This hypothesis is also supported by our
indirect observation that the construct C(1–600) binds
tighter to FoxM1 recognition sequences. Unfortunately,
the DBD construct used in our biophysical assay lacked
this domain and it proved diﬃcult to express a
well-behaved version due to degradation. In the present
structure, the residues immediately prior to the central
domain are ordered and adopt a unique strand-like
Nucleic Acids Research, 2010, Vol.38, No. 13 4535Figure 5. Transcription activation assays and genomic search for Fox consensus sequences. (A) Luciferase reporter assays showing the
FoxM1-mediated transcription rates from a Forkhead consensus promoter for wild type full-length protein or the L291Y mutant. As a control
the western blot showing the cell-lysates expression levels of each protein is at the bottom of the ﬁgure. (B)The left panel shows a histogram of the
number of forkhead consensus sites in either orientation found within the 3000bp upstream of each gene in human genome colored in grey. Overlaid
Continued
4536 Nucleic Acids Research, 2010, Vol.38, No. 13conformation that extends away from the DNA. It is dif-
ﬁcult to extend any conclusions from this substructure
about where the central domain would be positioned
with respect to the remainder of the molecule.
CONCLUSIONS
We have obtained the structure of the FoxM1-DBD and
measured its aﬃnity for a number of DNA sequences.
Unlike other DNA bound winged helix structures
FoxM1 displays a relatively short ﬁrst wing loop that
does not interact with the DNA. In addition, our structure
shows no evidence for the presence of the second wing
loop found within other Fox proteins, indicating that
this DNA-binding element is missing or migrated to a
distal segment of the full-length protein. As compared to
other family members, these subtle changes appear to
result in a lower aﬃnity and selectivity of FoxM1 for its
consensus recognition sequence. We also show that se-
quences outside the DBD are likely directly or indirectly
involved to infer higher aﬃnity and selectivity toward
promoter regions. Finally, structural, functional and bio-
informatics data show no preference of FoxM1 for
tandem recognition sequences. Should FoxM1 maintain
its moniker, ‘Trident’, it is important that the consensus
site be derived from the full-length protein and not the
isolated DBD, in a physiological context.
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